Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study

Tian Zhi Lim, View ORCID ProfileJerrald Lau, Gretel Jianlin Wong, View ORCID ProfileKer-Kan Tan
doi: https://doi.org/10.1101/2020.05.11.20097881
Tian Zhi Lim
1Saw Swee Hock School of Public Health, National University of Singapore;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tian_zhi_lim@nuhs.edu.sg
Jerrald Lau
2Saw Swee Hock School of Public Health, National University of Singapore;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jerrald Lau
  • For correspondence: ephlxj@nus.edu.sg
Gretel Jianlin Wong
3Saw Swee Hock School of Public Health, National University of Singapore;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gretelwong@nus.edu.sg
Ker-Kan Tan
4Yong Loo Lin School of Medicine, National University of Singapore;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ker-Kan Tan
  • For correspondence: surtkk@nus.edu.sg surtkk@nus.edu.sg
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

BACKGROUND Screening for colorectal cancer (CRC) using the faecal immunochemical test (FIT) is widely advocated. Few studies have compared the rate of detecting colonoscopic pathologies in single compared to double FIT-positive follow-up colonoscopy-compliant individuals in a two-sample national FIT screening program.

OBJECTIVE To compare CRC incidence in double FIT-positive versus single FIT-positive individuals using a retrospective cohort of patients from a tertiary hospital in Singapore.

DESIGN Retrospective cohort study.

SETTING Data was extracted from one regional acute hospital in Singapore.

PARTICIPANTS 1,539 FIT-positive individuals from the national FIT screening program who were referred to the hospital from 1st January 2017 to 31st September 2019 for follow-up consultation and diagnostic colonoscopy.

MEASUREMENTS The exposure of interest was a positive result on both FIT kits. The main outcome was a follow-up diagnostic colonoscopy finding of CRC. The secondary outcome was a diagnostic colonoscopy finding of a colorectal polyp.

RESULTS Incidence density of CRC was 1.53 (95% CI = 0.61, 3.15) and 17.88 (95% CI = 11.67, 26.19) per 100,000 person-months, in the single and double FIT-positive group, respectively. This resulted in an incidence rate ratio of 11.71 (95% CI = 5.25, 29.08). Colorectal polyp detection was significantly higher (p < 0.01) in the double (107 of 157 participants; 68.2%) compared to the single (310 of 585 participants; 53.0%) FIT-positive group.

LIMITATIONS The key limitation of this study was the relatively small cohort derived from a single regional hospital, as this had the effect of limiting the number of incident cases, resulting in comparatively imprecise CIs.

CONCLUSIONS Double FIT-positive individuals are significantly more likely to have a colonoscopy finding of incident CRC or premalignant polyp than single FIT-positive individuals. Clinicians and policymakers should consider updating their CRC screening protocols accordingly.

FUNDING SOURCE This study was supported by the Singapore Population Health Improvement Centre (SPHERiC) [NMRC/CG/C026/2017_NUHS]. The funders had no role in the study design, execution, analyses, interpretation of the data, or decision to submit results. We confirm that all authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity and accuracy of the data analysis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the Singapore Population Health Improvement Centre (SPHERiC) [NMRC/CG/C026/2017_NUHS]. The funders had no role in the study design, execution, analyses, interpretation of the data, or decision to submit results. We confirm that all authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity and accuracy of the data analysis.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • DISCLOSURES: All authors have completed the ICMJE Form for Disclosure of Potential Conflicts of Interest (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.

Data Availability

The data that support the findings of this study are available from the corresponding author, KKT, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study
Tian Zhi Lim, Jerrald Lau, Gretel Jianlin Wong, Ker-Kan Tan
medRxiv 2020.05.11.20097881; doi: https://doi.org/10.1101/2020.05.11.20097881
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study
Tian Zhi Lim, Jerrald Lau, Gretel Jianlin Wong, Ker-Kan Tan
medRxiv 2020.05.11.20097881; doi: https://doi.org/10.1101/2020.05.11.20097881

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8557)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10292)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (249)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (166)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)